ReposiTrak (NYSE:TRAK) reported essentially flat fiscal third-quarter revenue while highlighting stronger profitability, continued cash generation and new strategic initiatives tied to food traceability, artificial intelligence and in-store execution.
On the company’s fiscal third-quarter 2026 conference call, Chief Financial Officer John Merrill said revenue was $5.9 million, unchanged from the prior-year quarter. He said the year-ago period benefited from elevated traceability onboarding activity ahead of the original FDA compliance deadlines, which contributed to approximately 16% revenue growth at that time. Following the FDA’s extension of the FSMA 204 compliance deadline, that level of accelerated onboarding did not recur in the latest quarter.
